Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision history now lists the latest release as v3.5.5, replacing the previous v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-08T03:41:11.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.
    Difference
    0.1%
    Check dated 2026-05-17T10:44:21.000Z thumbnail image
  4. Check
    45 days ago
    Change Detected
    Summary
    Update of the ClinicalTrials.gov page revision indicator from “v3.5.2” to “v3.5.3,” reflecting a platform/version change without altering the study’s recorded content.
    Difference
    0.1%
    Check dated 2026-04-25T18:03:46.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the history.
    Difference
    0.1%
    Check dated 2026-04-18T13:19:33.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the record history, and v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-20T20:13:39.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-06T18:20:27.000Z thumbnail image

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.